We’re excited to join the European Respiratory Society Annual Meeting alongside the scientific and patient community to share insights about advances in cystic fibrosis. Visit us at Booth C7.02 and learn more about our work: www.vrtx.com/our-science
Vertex Pharmaceuticals
Biotechnology Research
Boston, MA 382,066 followers
The Science of Possibility
About us
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
- Website
-
https://www.vrtx.com/
External link for Vertex Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 1989
- Specialties
- cystic fibrosis, alpha-1 antitrypsin deficiency (AATD), APOL1-mediated kidney diseases, sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, and type 1 diabetes mellitus
Locations
Employees at Vertex Pharmaceuticals
Updates
-
Today is Polycystic Kidney Disease (PKD) Awareness Day. As we work toward a potential treatment for autosomal dominant polycystic kidney disease (ADPKD), we’re proud to join the community in recognizing the patients, families and caregivers who are affected by this life-shortening genetic disease. Learn more about our work in ADPKD: https://lnkd.in/eubRY3Sq #PKDAwarenessDay #ADPKD
-
-
At Vertex, we’re committed to raising awareness and understanding to help improve the lives of people with serious diseases. This week, our Boston headquarters will be lit up in red, green and blue in honor of #SickleCellAwarenessMonth, #MuscularDystrophyAwarenessMonth and #PainAwarenessMonth. We proudly stand alongside the community of patients, caregivers and health care providers in the fight against these diseases.
-
-
For the 15th year, Vertex has earned a spot on the San Diego Business Journal Best Places to Work list! 🌟 With 25 different types of labs, our San Diego Research site is filled with passionate Vertexians who embrace innovation, live our culture and values, and are determined to make a difference in the lives of people living with serious diseases. Want to join this group of innovative scientists? Learn more about working at Vertex: https://lnkd.in/evk3zJtp
-
-
We’re honored to support the 2024 PAINWeek Conference during Pain Awareness Month this September and look forward to connecting with the community and learning about advances in the field of pain management. #PainAwarenessMonth #PAINWeek2024
-
-
Join us in wishing our 2024 Vertex Science Leaders Scholarship recipients the best of luck as they head into their first year of college! 🎓 🍀 Ready to hit the books, these future innovators spent their summer at Vertex exploring the world of biotech. Meet these outstanding students and find out what drives their passion for #STEM. https://lnkd.in/eyssNBDA
-
A big congratulations to Johnice Veals, HMCC, who leads global Vertex employee events, on being recognized with the Visionary Award at the Smart Women in Meetings Awards Gala. “We are so lucky to have Johnice as part of the team. She’s a visionary when it comes to employee engagement and event planning,” said Liz (Landry) Lukegord, head of internal communications. “She takes the time to connect with and understand her audience to create memorable experiences that help bring our unique Vertex culture to life.”
-
-
The same values that guide our science power our commitment to the communities where we live and work. Giving back to the community broadens our employees’ perspectives to help us continue to drive innovation forward. We’re intentional about every aspect, from what nonprofit organizations we collaborate with to creating opportunities for students who are underrepresented in biotech. We could tell you more, but it’s best to hear it from a few amazing Vertexians who say giving back makes their career more satisfying: https://lnkd.in/evpNSwgQ
Want to Love Your Job? Work for a Company That Cares About Its Community | InHerSight
inhersight.com
-
Service is second nature to members and allies of our BRAVE employee resource network, which recognizes our veteran and first responder communities across the globe. Serving our communities is one of the meaningful ways BRAVE and our other employee resource networks create impact. This year, BRAVE sponsored a team for the 15th Annual Run to Home Base to raise awareness and funds for Home Base, a U.S. national nonprofit that provides clinical care, wellness, education and research at no cost for veterans of all eras, service members, military families and families of the fallen. “As a United States Marine Corps veteran, I am running to help raise awareness and funding for organizations that support Military members as they transition out of service and back to civilian life.” - Josh Adams, facilities operations manager and BRAVE ERN global co-lead. #RTHB2024
-
-
-
-
-
+1
-
Similar pages
Browse jobs
Stock
VRTX
NASDAQ
20 minutes delay
$467.24
-11.33 (-2.368%)
- Open
- 477.73
- Low
- 463.41
- High
- 477.73
Data from Refinitiv
See more info on